New Age Alpha Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.75M Sell
8,428
-411
-5% -$417K 0.36% 58
2025
Q4
$9.5M Sell
8,839
-3,711
-30% -$3.55M 0.41% 43
2025
Q3
$9.58M Buy
12,550
+1,658
+15% +$1.23M 0.4% 44
2025
Q2
$8.49M Sell
10,892
-13
-0.1% -$10.1K 0.37% 55
2025
Q1
$9.01M Sell
10,905
-1,875
-15% -$1.56M 0.4% 53
2024
Q4
$9.87M Buy
+12,780
New +$10.6M 0.4% 53

Other funds holding LLY

New Age Alpha Advisors's LLY Position: Q1 2026 in Review

New Age Alpha Advisors reduced its Eli Lilly (LLY) stake by 4.6% in Q1 2026, selling an estimated $417K and leaving 8,428 shares worth $7.75M. The position accounts for 0.36% of the portfolio, ranked #58.

New Age Alpha Advisors first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $9.87M in Q4 2024. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • New Age Alpha Advisors held 8,428 shares of Eli Lilly worth $7.75M as of Q1 2026.
  • New Age Alpha Advisors sold 411 Eli Lilly shares in Q1 2026, an estimated $417K.
  • Eli Lilly made up 0.36% of New Age Alpha Advisors's portfolio in Q1 2026, its #58 holding.
  • New Age Alpha Advisors first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • New Age Alpha Advisors's Eli Lilly position peaked at $9.87M in Q4 2024.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on New Age Alpha Advisors's 13F filing for Q1 2026, filed 11 May 2026.